Partial Status Epilepticus after Electroconvulsive Therapy and Medical Treatment with Bupropion

 

 Buy Article Permissions and Reprints

Abstract

Electroconvulsive therapy (ECT) is the most effective treatment for therapy-refractory depression. Usually, prior antidepressant medication will be continued during ECT. However, the seizure threshold may be influenced by psychotropic drugs. We report a patient who received right unilateral ECT under concomitant treatment with bupropion, a selective noradrenaline- and dopamine-reuptake inhibitor. After the fourth session, a focal status epilepticus occurred, which was pharmacoresistant for the duration of 12 days. We assume that the induction of a status may be facilitated by a lowering of the seizure threshold due to bupropion. An evaluation of drug therapy and control of EEG before and during ECT are recommended, especially when the drug treatment has an influence on the seizure threshold.

• References

• 1 Sheehan DV, Welch JB, Fishman SM. A case of bupropion-induced seizure. J Nerv Ment Dis 1986; 174: 496-498
  PubMedGoogle Scholar
• 2 Dhillon S, Yang LPH, Curran MP. Bupropion – a review of its use in the management of major depressive disorder. Drugs 2008; 68: 653-689
  CrossrefPubMedGoogle Scholar
• 3 Fava M, Rush AJ, Thase ME et al. 15 years of clinical experience with bupropion HCL: From bupropion to bupropion SR to bupropion XL. Prim Care Companion J Clin Psychiatry 2005; 7: 106-113
  CrossrefPubMedGoogle Scholar
• 4 Povlsen U, Wildschiødtz G, Høgenhaven H et al. Nonconvulsive status epilepticus after electroconvulsive therapy. J ECT 2003; 19: 164-169
  CrossrefPubMedGoogle Scholar
• 5 Baghai T, Marcuse A, Brosch M et al. The influence of concomitant antidepressant medication on safety, tolerability and clinical effectiveness of electroconvulsive therapy. World J Biol Psychiatry 2006; 7: 82-90
  CrossrefPubMedGoogle Scholar
• 6 Lisanby SH, Resor SR, Nobler MS et al. ECT in the treatment of status epilepticus. J ECT 2001; 17: 210-215
  CrossrefPubMedGoogle Scholar
• 7 Figiel GS, Jarvis MR. Electroconvulsive therapy in a depressed patient receiving bupropion. J Clin Psychopharmacol 1990; 10: 376
  CrossrefPubMedGoogle Scholar
• 8 Conway CR, Nelson LA. The combined use of bupropion, lithium, and venlafaxine during ECT: a case of prolonged seizure activity. J ECT 2001; 17: 216-218
  CrossrefPubMedGoogle Scholar
• 9 Kellner CH, Pritchett JT, Jackson CW. Bupropion coadministration with electroconvulsive therapy: two case reports. J Clin Psychopharmacol 1994; 14: 215-216
  CrossrefPubMedGoogle Scholar
• 10 Patel AS, Gorst-Unsworth C, Venn RM et al. Anesthesia and electroconvulsive therapy: a retrospective study comparing etomidate and propofol. J ECT 2006; 22: 179-183
  CrossrefPubMedGoogle Scholar
• 11 Khalid N, Atkins M, Kirov G. The effects of etomidate on seizure duration and electrical stimulus dose in seizure-resistant patients during electroconvulsive therapy. J ECT 2006; 22: 184-188
  CrossrefPubMedGoogle Scholar
• 12 Rassmussen KG, Lunde ME. Patients who develop epilepsy during extended treatment with electroconvulsive therapy. Seizure 2007; 16: 266-270
  CrossrefPubMedGoogle Scholar
• 13 Fink M, Petrides G, Kellner C et al. Change in seizure threshold during electroconvulsive therapy. J ECT 2008; 24: 114-116
  CrossrefPubMedGoogle Scholar
• 14 Devinsky O, Duchowny MS. Seizure after convulsive therapy: a retrospective case survey. Neurology 1983; 33: 921-925
  CrossrefPubMedGoogle Scholar